Clinical Trial Update: An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome [Phase 2]

View source ↗

Summary

Open-label Phase 2 pilot study update evaluating the efficacy and safety of Piclidenoson for Lowe syndrome, sponsored by Can-Fite BioPharma; the trial is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lowe Syndrome

Drugs mentioned

• Piclidenoson (Piclidenoson)

Snippet

Sponsor: Can-Fite BioPharma | Conditions: Lowe Syndrome | Phase 2 | Status: NOT_YET_RECRUITING